Get the SPI Wire

OSR HEALTH, INC.

NASDAQ:OSRH
Annual Meeting

of Shareholders

MEETING DATE

08/07/2026
DEF 14A FILED
07/16/2026
PUBLISHED
07/16/2026 8:36 pm
TIME TO PUBLISH
07/18/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:OSRH · CUSIP 68840D102 · CIK 0001840425

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

9
FOR
1
AGAINST
0
WITHHOLD
10
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1a
Kuk Hyoun Hwang
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated this current director to serve until the next annual meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1b
Jun Chul Whang
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated this current director to serve until the next annual meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1c
Alcide Barberis
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated this current director to serve until the next annual meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1d
Seng Chin Mah
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated this current director to serve until the next annual meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1e
Hyuk Joo Jee
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated this current director to serve until the next annual meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1f
Joong Myung Cho
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated this current director to serve until the next annual meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1g
Reto Fierz
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated this current director to serve until the next annual meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of Independent Auditor
auditor
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Audit Committee appointed Shinhan Accounting Corporation for the fiscal year ending December 31, 2026.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Executive Compensation Proposal
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

No stock-based compensation awards were granted prior to the filing date.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Authorized Shares Increase Proposal
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states future share issuances could dilute existing stockholders’ voting power and economic interests.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates